Saliva is less sensitive than nasopharyngeal swabs for COVID-19 detection in the community setting
David Becker, Efren Sandoval, Aakash Amin, Peter De Hoff, Amberly Diets, Nicole Leonetti, Yan Wei Lim, Christie Elliott, Louise Laurent, View ORCID ProfileJoseph Grzymski, View ORCID ProfileJames Lu
doi: https://doi.org/10.1101/2020.05.11.20092338
Abstract
The use of saliva collection for SARS-CoV-2 diagnostics in the ambulatory setting provides several advantages when compared to nasopharyngeal swabs (NPS), including ease of self-collection and reduced use of personal protective equipment (PPE). In addition saliva collection could be advantageous in advising if a convalescent patient is able to return to work after a period of self-quarantine. We investigated the utility of saliva collection in the community setting at Renown Health in a prospective Diagnostic Cohort of 88 patients and in a Convalescent Cohort of 24 patients. In the Diagnostic Cohort, we find that saliva collection has reduced sensitivity (~30% less) relative than NPS. And in our convalescent cohort of patients greater than 8 days and less than 21 days from first symptom, we find that saliva has ~ 50% sensitivity relative to NPS. Our results suggest that rigorous studies in the intended populations should be performed before large-scale screening using saliva as the test matrix is initiated.
*注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.